M&T Bank’s VanEck Biotech ETF BBH Stock Holding History

M&T Bank’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,785	Closed	-$279K	–	1607
2023 Q2	$279K	Buy	+1,785	New	+$285K	﹤0.01%	1337

Other funds holding BBH

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CIG

Consolidated Investment Group Englewood, Colorado $922M AUM 28.87% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

M&T Bank's BBH Position: Q3 2023 in Review

M&T Bank sold out of VanEck Biotech ETF (BBH) in Q3 2023, closing a stake of 1,785 shares — an estimated $279K sold.

M&T Bank first reported a position in BBH in Q2 2023 and held it in 1 quarter. The position peaked at $279K in Q2 2023. 110 funds tracked by Wall St. Rank hold BBH as of Q3 2023.

M&T Bank reported no remaining VanEck Biotech ETF position as of Q3 2023 after selling out during the quarter.
M&T Bank sold 1,785 VanEck Biotech ETF shares in Q3 2023, an estimated $279K.
M&T Bank first reported a position in VanEck Biotech ETF in Q2 2023 and held it in 1 quarter.
M&T Bank's VanEck Biotech ETF position peaked at $279K in Q2 2023.
110 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q3 2023.

Based on M&T Bank's 13F filing for Q3 2023, filed 2 Nov 2023.